|
Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis |
Eng C, Kramer CK, Zinman B, Retnakaran R |
|
|
Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Eng C, Kramer CK, Zinman B, Retnakaran R. Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis. Lancet 2014: epub Indexing Status Subject indexing assigned by NLM MeSH Diabetes Mellitus, Type 2 /drug therapy; Drug Therapy, Combination; Hemoglobin A, Glycosylated /analysis; Humans; Hypoglycemic Agents /therapeutic use; Insulin, Long-Acting /therapeutic use; Randomized Controlled Trials as Topic; Receptors, Glucagon /agonists; Weight Loss AccessionNumber 12014058500 Date bibliographic record published 26/09/2014 |
|
|
|